EsThe Chinese government will hold training programs for Indian pharmaceuticals manufacturers to help them better understand Chinese regulatory systems and promote exports the Economic Times reports. That comes hot on the heels of an apparent agreement between President Xi Jinping and Prime Minister Narendra Modi to push bilateral trade to $100 billion per year by 2020 from $88 billion in the 12 months to April 30 as outlined in Panjiva research of June 11.
Panjiva data shows Indian pharmaceutical exports reached $11.3 billion in the 12 months to March 31 after climbing 37.5% in the first quarter on a year earlier after a 17.3% drop in 2017 vs. 2016. Shipments to China were negligible with the United States the dominant client nation with 32.9% of imports in the past 12 months.
Source: Panjiva
The leading exporters which may benefit from the Chinese program to diversify their supplies include Mylan ($1.02 billion of exports in the past 12 months or 9.0% of the total), Cipla ($716 million) and Dr. Reddy’s ($634 million).
Source: Panjiva
